Thiessen B, Pedersen O F
Scand J Respir Dis Suppl. 1979;103:170-7.
8 normals, 8 asthmatics and 8 bronchitics inhaled comparable doses of ipratropin and salbutamol. Five different flow-volume parameters were measured before and at intervals from 3 to 360 minutes after inhalation, on a total number of 2880 maximal effort expiratory flow-volume curves. Arterial blood gas tensions were measured before and 60 minutes after inhalation. In all parameters a significant larger effect (p less than 0.05) of ipratropin was found in normals, but in different time intervals. The parameter FEV1 and MEF at 50% of FVC showed the largest effect of salbutamol during the interval from 3 to 60 minutes in the asthma patients. None of the parameters showed significant difference in drug effects in the bronchitis patients. The findings suggested a more peripheral action of ipratropin than of salbutamol in the normals. No significant change in gas tensions were found after inhalation in any of the three groups.
8名正常人、8名哮喘患者和8名支气管炎患者吸入了相当剂量的异丙托溴铵和沙丁胺醇。在吸入前以及吸入后3至360分钟的不同时间间隔,测量了5种不同的流量-容积参数,共获得2880条最大用力呼气流量-容积曲线。在吸入前和吸入后60分钟测量动脉血气张力。在所有参数中,正常人吸入异丙托溴铵后均有显著更大的效应(p<0.05),但在不同的时间间隔。在哮喘患者中,在3至60分钟的时间间隔内,FEV1和FVC的50%时的MEF参数显示沙丁胺醇的效应最大。在支气管炎患者中,没有参数显示药物效应有显著差异。研究结果表明,在正常人中,异丙托溴铵的作用比沙丁胺醇更具外周性。三组患者吸入后血气张力均未发现显著变化。